Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dr Lal PathLabs Selects STARLIMS Software for LIMS

Published: Tuesday, November 29, 2011
Last Updated: Tuesday, November 29, 2011
Bookmark and Share
STARLIMS will be implemented for use in its entire network consisting of the National Reference Lab (NRL) in New Delhi

Dr Lal PathLabs, India’s diagnostics leader, has selected STARLIMS, an Abbott company, as the provider of its new Laboratory Information Management System (LIMS). STARLIMS will be implemented for use in its entire network consisting of the National Reference Lab (NRL) in New Delhi, approximately 100 satellite labs and 1,000 collection centres all over India. The main solution will be installed at its hub at the NRL at Rohini, Delhi.

Dr Lal PathLabs tests around 21,000 patients daily at NRL which is equipped with state-of-the-art technologies, laboratory professionals, spread over 85,000 sq ft., providing some of the fastest turn-around-times (TAT) in the industry. Dr Lal PathLabs performs over 30 million tests annually and STARLIMS will be used to manage the entire testing life cycle - from sample login to reporting.

“Knowing that our legacy system was being phased out, we searched for a new information management solution that would guarantee the reliability and quality of each test we perform, in every lab discipline. STARLIMS can do all that, while also enhancing our communications with our laboratories and sample collection sites across the country,” said Dr Arvind Lal, Chairman and MD.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Food and Drug Administration will begin implementing Abbott’s STARLIMS LIMS as part of the agency’s initiative to enhance FDA testing laboratories.
Monday, July 09, 2012
STARLIMS Acquires Distributor in Australia
Abbott has acquired STARLIMS’s Asia Pacific distribution partner.
Saturday, June 02, 2012
STARLIMS Expanding Global Market Presence in Forensics
STARLIMS is expanding its worldwide presence in the forensics market with products and applications designed for crime labs, evidence collection teams and police property rooms.
Saturday, June 02, 2012
Samsung Biologics Chooses STARLIMS
STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results.
Saturday, June 02, 2012
STARLIMS to Provide LIMS to Australian Red Cross Blood Services
STARLIMS' LIMS software has been adopted by the Australian Red Cross Blood Services (ARCBS) to manage information and data in its blood products manufacturing and transplantation laboratories.
Saturday, June 02, 2012
Abbott’s STARLIMS Business Acquires Distribution Partners to Build International Presence
Acquisitions part of a series of strategic moves to build Abbott's LIMS business in Europe and emerging markets in Latin America and Africa
Saturday, May 12, 2012
STARLIMS Expands Global Customer Service and Support
Resources from Abbott help build new, global customer care organization
Wednesday, April 25, 2012
STARLIMS Acquires International Distribution Partners
STARLIMS Technologies, an Abbott company, has announced the acquisition of several longtime distribution partners
Sunday, March 11, 2012
StarLIMS wins FDA software deal
The company will supply its lab management solutions for FDA testing laboratories.
Wednesday, February 01, 2012
Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
STARLIMS and Abbott have announced that the FDA will begin implementing STARLIMS LIMS solution as part of the agency’s initiative to enhance FDA’s testing laboratories.
Tuesday, January 24, 2012
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!